Stockreport

Kodiak Sciences (KOD) Is Up 66.3% After Strong Zenkuda GLOW2 Phase 3 Data - Has The Bull Case Changed? [Yahoo! Finance]

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF sham in treating a broad range of diabetic retinopathy patients with extended-interval intravitreal dosing and a favorable safety profile. An interesting aspect of GLO [Read more]